Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

WOONSOCKET, R.I., Oct. 23, 2020 /PRNewswire/ -- CVS Health Corporation ("CVS Health") (NYSE:CVS) will hold a conference call with analysts and investors on Friday, November 6, 2020, at 8:00 a.m. (ET) to discuss its financial results for the third quarter of 2020. An audio webcast of the...

CVS Health Corporation To Hold Third Quarter 2020 Earnings Conference Call

Pinterest

You don't need to begin with a mountain of cash to build wealth on Wall Street.

3 Great Stocks to Buy Right Now With $75

Chevron

Enbridge

Enterprise Products Partners

International Paper

Kinder Morgan

LTC Properties

Magellan Midstream Partners

Pembina Pipeline

Public Storage

AT&T

Toronto-Dominion Bank

W. P. Carey

Exxon Mobil

Kiplinger Investing periodically lists retirement tips. This 41-stock list comes from two articles. One by Brian Bollinger, updated 8/5/20 and another by Charles Lewis Sizemore, CFA, 7/2/19. Articles titled, '20 for 20 retirement years' and '25 stocks every retiree should own' listed four stocks twice, leaving 41. One ceased paying dividends and one never did, leaving 39.

Found: 17 Reliable, Buyable Dividend Stocks For Retirees In October (Of 41)

Allstate

Apollo Global Management

Dollar General

Lockheed Martin

O'Reilly Automotive

One of the best ways investors can build a more diverse and stable portfolio that offers value is through investing in high-quality companies that are undervalued by market standards. Our AI algorithms have identified some of these standout value stocks for the month.

Top Value Stocks For October

Amedisys

Meritage Homes

Insperity

Vertex Pharmaceuticals

A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Meritage Homes (MTH), Vertex Pharmaceuticals (VRTX), CVS Health (CVS), Amedisys (AMED) and Insperity (NSP) are sound enough to meet financial obligations.

Pick These 5 Stocks With Superb Interest Coverage Ratio

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.

PreMarket Prep Stock Of The Day: CVS Health

CVS Health said Monday it is hiring 15,000 people to administer COVID-19 tests and flu vaccinations as it prepares for an expected surge in cases this fall and winter. More than 10,000 of the new hires will be licensed pharmacy technicians who can give COVID-19 tests — and who the company hopes will also be.

CVS hiring 15,000 as it braces for more COVID-19 cases this fall

CVS Health is hiring 15,000 more employees in addition to the 50,000 previously hired as it braces for an onslaught of more Covid-19 and flu cases.

CVS is filling thousands of pharmacy jobs as it braces for the next wave of Covid-19

Shares of CVS Health Corp. gained 0.6% in premarket trading on Monday after the retail giant announced plans to hire 15,000 full-time and part-time workers in the fourth quarter as it prepares for rising cases of COVID-19 and flu season. Two-thirds of the jobs are for licensed pharmacy technicians, a group of professionals that CVS wants to be allowed to administer COVID-19 vaccines, if and when they become available.

CVS to hire 15,000 workers as it pushes for pharmacy techs to be allowed to administer vaccines

WOONSOCKET, R.I., Oct. 19, 2020 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that it is recruiting qualified candidates to fill 15,000 jobs. These new and existing positions will help the company continue to respond to the needs of communities across the country during the fall...

CVS Health to Hire 15,000 Across the U.S. in Fourth Quarter

Pharmacy chain CVS Health Corp will hire 15,000 employees as the onset of winter could fuel a resurgence in the spread of COVID-19 and flu cases, CNBC reported on Monday.

CVS to hire 15,000 workers to prepare for more COVID-19 cases: CNBC

CVS Health Corp (NYSE: CVS) said Monday it plans to add 15,000 staffers on a priority basis, Bloomberg reports. A major portion of new hires would include licensed pharmacists, as the company prepares for the flu season, along with ramping up COVID-19 testing.

CVS Health To Add 15,000 Staffers As It Prepares For Flu Season, COVID-19 Vaccine Rollout

More than 10,000 of the new hires will be full-time and part-time pharmacy technicians who can help dispense medications and administer Covid-19 tests.

CVS to hire thousands of pharmacy techs as it prepares for more Covid-19 cases, rollout of vaccine

CVS Health will hire 15,000 full and part-time workers as the company braces for an influx of customer needs during seasonal influenza season and the ongoing Covid-19 pandemic.

CVS Health To Hire 15,000 Workers As Seasonal Flu And Covid-19 Collide

Walgreens

The Trump administration has worked out a deal with America's largest retail pharmacy chains.

CVS Health and Walgreens to Administer Free Coronavirus Vaccines

WOONSOCKET, R.I., Oct. 16, 2020 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today it will be providing COVID-19 vaccinations to long-term care facilities throughout the country when the vaccine becomes available. "CVS Health has been on the front lines of the fight against COVID-19,...

CVS Health to Partner with Long-term Care Facilities When COVID-19 Vaccine is Available

Hewlett Packard

Intel

Kroger

Lennar

Mylan

Molson Coors Brewing

Tapestry

Tyson Foods

Two traders sift through a group of stocks "on sale" to find bargain buys in the market.

These stocks trading at discounts to their valuations may be worth buying, traders say

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is CVS Health (CVS) a Great Value Stock Right Now?

Best Buy

Pacer US Cash Cows 100 ETF

Discovery

Gilead Sciences

Altria

Target

One way to find undervalued stocks is to use free cash flow yield as a barometer. Here are 10 stocks to buy based on this criterion.

10 Undervalued Stocks to Buy From the Pacer US Cash Cows 100 ETF

AbbVie

AmerisourceBergen

AvalonBay Communities

Cisco Systems

Federal Realty Investment Trust

General Dynamics

Realty Income Corp

Prudential Financial

Reinsurance Group of America

Siemens AG

Snap-on

Simon Property Group

The time has come once again to look at what sort of companies you'll want to be buying, this time as we move into October of 2020.

October 2020 Stocks: Financials, Real Estate, Industrials, IT And Pharma

News for CVS Health Stock (CVS)